$80K fine for Aussie Code Breach

Posted 20 November 2024 PM

AstraZeneca has been fined $80,000 and forced to withdraw material relating to its COPD inhaler Breztri Aerosphere after being found in breach of the Medicines Australia Code of Conduct following a complaint by rival company Chiesi.

The complaint centred around AstraZeneca's Go for Gold campaign which Chiesi alleged misled by inference that the product was 'the best' and superior to other inhaler therapies. Chiesi said this claim was an "unsubstantiated, superlative and disparaging to other triple therapies" and was amplified due to timing with the Olympic campaign. It also said it was inconsistent with its approved Product Information which describes the device as having a yellow plastic actuator, not gold.

To see the whole article, please login